Sveriges mest populära poddar
The Long Run with Luke Timmerman
Vetenskap

Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases

1 tim 18 min•11 augusti 2026
Jason Coloma, CEO of South San Francisco-based Maze Therapeutics, on developing small molecule drugs based on human genetics for kidney diseases.

Fler avsnitt av The Long Run with Luke Timmerman

Visa alla avsnitt av The Long Run with Luke Timmerman
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
•1 tim 7 min
Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases
•1 tim 7 min
Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With
•1 tim 8 min
Ep204: Troy Wilson on Precision Cancer Drugs and Combos
•1 tim 7 min
Ep203: Sri Kosuri on Small Molecule Correctors of Disease
•1 tim 12 min
Ep202: Becky Pferdehirt on Reimagining Science for the AI Era
•1 tim 8 min
Ep201: Jeremy Levin on Biotech in the Balance
•1 tim 9 min
Ep200: Richard Pops Reflects on a 35-Year Career in Biotech
•1 tim 14 min
Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era
•1 tim 10 min
Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery
•1 tim 17 min

The Long Run with Luke Timmerman med Timmerman Report finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.